Related Experiment Video
Updated: Apr 12, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Adrenal function and microbial DNA in noninfected cirrhotic patients with ascites: Relationship and effect on
Alessandro Risso1, Carlo Alessandria1, Lavinia Mezzabotta1
1Division of Gastroenterology and Hepatology, AOU Città della Salute e della Scienza di Torino, University of Turin, Italy.
Background:
There are few data on clinical relevance of adrenal dysfunction and its relationship with occult microbial DNA in noninfected haemodynamically stable cirrhotic patients with ascites.
Aims:
The aim of this study was to evaluate prognostic role of adrenal dysfunction, microbial DNA, and their relationship.
Methods:
Adrenal function was assessed in 93 consecutive patients following a corticotropin stimulation test. Adrenal dysfunction was defined as: basal cortisol <10 μg/dl, delta cortisol <9 μg/dl, or peak cortisol <18 μg/dl. Microbial DNA was assessed in blood and ascites of 54 consecutive patients. Patients were followed up until liver transplantation or death.
Results:
Adrenal dysfunction was not significantly associated with mortality, while the risk of death rose significantly with an increase in basal cortisol values (HR 1.13 per 1-μl/dl increase; 95% CI 1.01-1.26). Microbial DNA was independently associated with reduced survival (HR 8.05, 95% CI 1.57-41.2). In microbial DNA-positive patients a significant correlation was found between Model for End-Stage Liver Disease (MELD) score and basal cortisol values (Pearson's r=0.5107; p=0.018).
Conclusions:
Microbial DNA and MELD score, but not adrenal function, were the best independent predictors of mortality in noninfected cirrhotic patients with ascites. High serum cortisol levels may be a systemic reaction to microbial translocation, increasing in parallel with deterioration of liver function.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

